troglitazone has been researched along with Anorexia in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.
Excerpt | Relevance | Reference |
---|---|---|
"Recently, we found that profound anorexia observed in a catabolic model induced by chronic glucocorticoid (dexamethasone, Dex) injection could be associated with strong hyperleptinemia." | 3.73 | Troglitazone reduces leptinemia during experimental dexamethasone-induced stress. ( Caldefie-Chézet, F; Enreille-Leger, A; Poulin, A; Vasson, MP, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caldefie-Chézet, F | 1 |
Poulin, A | 1 |
Enreille-Leger, A | 1 |
Vasson, MP | 1 |
1 other study available for troglitazone and Anorexia
Article | Year |
---|---|
Troglitazone reduces leptinemia during experimental dexamethasone-induced stress.
Topics: Adipocytes; Adipose Tissue; Animals; Anorexia; Blood Glucose; Body Weight; Chemical and Drug Induced | 2005 |